[et_pb_section fb_built=\u201d1\u2033 _builder_version=\u201d4.16\u2033 global_colors_info=\u201d{}\u201d][et_pb_row _builder_version=\u201d4.16\u2033 background_size=\u201dinicial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201drepetir\u201d global_colors_info=\u201d{}\u201d][et_pb_column type=\u201d4_4\u2033 _builder_version=\u201d4.16\u2033 custom_padding=\u201d|||\u201d global_colors_info=\u201d{}\u201d custom_padding__hover=\u201d|||\u201d][et_pb_image src=\u201dhttps:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2024\/10\/landscapelogos2000-x-1000-px.png\u201d title_text=\u201dlandscapelogos(2000 x 1000 px)\u201d url=\u201dhttps:\/\/www.charitynavigator.org\/ein\/043460220\u2033 align=\u201dcenter\u201d admin_label=\u201dlogos\u201d _builder_version=\u201d4.27.0\u2033 _module_preset=\u201ddefault\u201d width=\u201d100%\u201d max_width=\u201d100%\u201d global_colors_info=\u201d{}\u201d][\/et_pb_image][et_pb_text _builder_version=\u201d4.27.0\u2033 text_font_size=\u201d18px\u201d background_size=\u201dinicial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201drepetir\u201d global_colors_info=\u201d{}\u201d]<\/p>\n
Estamos de volta! A PRF est\u00e1 entusiasmada em anunciar o in\u00edcio de um novo ensaio cl\u00ednico de Progeria com um novo medicamento chamado Progerinin. A PRF ajudar\u00e1 a financiar e coordenar este ensaio para determinar se um novo medicamento, chamado Progerinin, mais o medicamento prolongador de vida para Progeria, lonafarnib (Zokinvy), \u00e9 mais ben\u00e9fico do que o lonafarnib sozinho.<\/p>\n